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Abstract   
 
 
Background: Diabetes is a rapidly growing epidemic that, to a degree, is both caused by 
and managed with diet. Vegetarian and vegan diets are associated with a reduced risk of 
diabetes, and have been shown to increase insulin sensitivity and decrease body weight. 
This study sought to review trials that directly compare a vegetarian or vegan diet to a 
conventional diabetes diet with the outcome of improved management, as measured by 
weight loss, reduction in medication use and glycated hemoglobin (HbA1c).  
 
Method: An extensive literature search was performed using MEDLINE-OVID, 
CINAHL, Evidence-Based Medicine Reviews Multifile and Web of Science to include 
randomized controlled trials (RCTs) directly comparing a vegetarian or vegan diet to a 
conventional diabetes diet. The following search terms were used: “Diabetes or Diabetes 
Mellitus or Diabetes Mellitus, Type 2” and “Vegan diet or Diet, vegetarian.” The quality 
of evidence presented in each article was assessed using the GRADE (Grading of 
Recommendations Assessment, Development and Evaluation) criteria.  
 
Results:  Three RCTs were included in the review. Diabetics assigned to the 
experimental group reduced or stopped hypoglycemic medications significantly more 
than those in the control group. The effect of diet on HbA1c was not significant in any 
study based on intention-to-treat analyses, but in sub-group analyses accounting for 
medication change, the vegan/vegetarian group indicated a greater reduction in two 
studies. Weight loss was significant within each diet group, and two studies found it to be 
significantly greater in the vegetarian group. 
 
Conclusion: Individuals with type 2 diabetes who participate in vegan and vegetarian 
diets effectively lose weight and have better glycemic control as measured by medication 
reduction than those following a conventional diabetes diet.  
 
Keywords:  diabetes, type 2 diabetes, vegan diet, vegetarian diet, conventional diabetes 
diet, glycemic control, weight loss, management 
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Improved Management of Type 2 Diabetes With a Plant-Based Diet Compared to a 
Conventional Diabetes Diet 
BACKGROUND 
 Type 2 diabetes is a rapidly growing epidemic, and according to a 2011 CDC 
report, it accounts for 90-95% of the 25.8 million cases of diabetes in the United States.1 
The American Diabetes Association recommends weight loss and dietary strategies as 
integral components of diabetes management, with loose guidelines to individualize the 
macronutrient composition based on patient’s conditions and preferences, and to monitor 
carbohydrates, maintain saturated fat intake <7% of total calories and minimize intake of 
trans fat.2  
A large body of evidence suggests vegetarian and vegan diets are associated with 
a reduced risk of many chronic diseases, including diabetes.3-5 In two separate large-scale 
cohort studies of more than 86 000 Seventh-day Adventists, a population almost equally 
divided between vegetarians and omnivores who generally avoid alcohol, tobacco and 
caffeine, the prevalence of diabetes was significantly lower in vegetarians compared to 
omnivores.3,4 Researchers have also related vegetarian and vegan diets with increased 
insulin sensitivity,6-8 and a lower body weight.3,5,7,9,10 In contrast, other studies have 
linked diets that include meat, particularly processed and/or red meat, as positively 
correlated with incidence of diabetes.11-13 A variety of possible mechanisms have been 
proposed and studied to explain the beneficial effects of a plant-based diet, including 
increased fiber14-16, reduced saturated fat8,14, reduced total protein17, and reduced heme-
iron from animal protein in particular.18 Moreover, studies have shown acceptability of a 
vegan diet to be comparable with that of other therapeutic diets.19,20 On that account, a 
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plant-based diet with emphasis on fiber, whole grains, legumes, vegetables and fruit may 
provide benefit for management of type 2 diabetes over diets that include meat.  
This study sought to review trials that directly compare a vegetarian or vegan diet 
to a conventional diabetes diet with the outcome of improved management, as measured 
by weight loss, reduction in medication use and HbA1c.  
 
METHODS  
An extensive literature search was performed using MEDLINE-OVID, CINAHL 
and Evidence-Based Medicine Reviews Multifile with the following keywords: “Diabetes 
or Diabetes Mellitus or Diabetes Mellitus, Type 2” and “Vegan diet or Diet, vegetarian.” 
The search was further limited to humans and English language. Inclusion criteria 
comprised of those studies directly comparing a vegetarian or vegan diet to a 
conventional diabetes diet conducted in a randomized controlled trial method. After 
eliminating duplicates and reviews, Web of Science was utilized for a cited reference 
search of remaining articles.  
 
RESULTS  
The searches identified 152 articles, of which all but 4 were excluded. The 
forward-cited reference search did not provide any additional studies that compared a 
vegan or vegetarian diet to a diabetes diet. Two of the 4 studies use the same participant 
population with one paper written after 22 weeks and the second after 74 weeks of the 
study, so for the purposes of this systematic review, the long-term data was selected for 
analysis and a total of 3 articles were reviewed (see Table 1). The following outcomes of 
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interest were examined based on clinical relevance and commonality among the studies: 
1) medication reduction 2) HbA1c and 3) weight loss. 
Nicholson et al 
 Methods—This study was intended as a 12-week pilot investigation to assess 
dietary intervention on management of DM II (Diabetes Mellitus Type 2), in a 
randomized, controlled design. Thirteen subjects were recruited through newspaper 
advertisements in the Washington, DC area. Individuals greater than 25 years of age with 
DM II willing to attend all components of the study were included. Exclusionary criteria 
included smoking, regular alcohol use, current or past drug abuse, pregnancy, psychiatric 
illness, and medical instability. Individuals were randomly assigned to either a low-fat 
vegan diet (n=7) or a control diet (n=6). Two control subjects dropped out and were not 
included in analyses. The vegan diet consisted of whole grains, vegetables, legumes, and 
fruit and excluded animal products, added oils, sugars and refined carbohydrates. 
Calories were divided among macronutrients in the following manner: 10-15% from 
protein, <10% from fat, and the remaining from carbohydrates. Cholesterol content was 
zero. The control diet was designed to derive 10-15% of calories from protein, <30% 
from fat, and 55-60% from carbohydrates. Cholesterol was limited to 200 mg per day. 
Participants had the option of eating provided lunches and dinners throughout the study 
period and attended twice-weekly cooking and nutrition classes. Adherence to the 
assigned diets was assessed with periodic submission of 3-day dietary records at baseline 
and again at 12 weeks, in addition to weekly self-report questionnaires handed out at 
group meals. Biweekly, participants met with the medical director or nurse-project 
coordinator to assess medication needs, which were altered according to protocol as 
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necessary. Exercise habits were collected by self-reports at baseline and again at 12 
weeks, and no recommendations were made. The following were measured during the 
study: blood pressure, weight, fasting serum glucose, fasting serum lipids, glycosylated 
hemoglobin, and urinary microalbumin.21 
 Results—Although not included in outcome analyses, the authors reported good 
adherence by all subjects to their diet as monitored by verbal reports, with the exception 
of two experimental group participants who later indicated several lapses in compliance. 
Five out of 7 vegan participants had to reduce either oral hypoglycemic agents or insulin, 
whereas no changes were made in the control group. There was a reduction in mean 
HbA1c in the experimental group from 8.3 (SD 1.7) at baseline to 6.9 (SD 1.1) after 12 
weeks. The control group started at an average HbA1c 8.0 (SD 1.1) and dropped to 7.0 
(SD 0.6) after 12 weeks. Sub-analyses to control for medication changes were not 
performed, and raw data were not available. There was a mean weight loss of 7.2 kg in 
the experimental group, compared to an average loss of 3.8 kg in the control group 
(P<0.005).21  
Barnard et al 
 Methods—The purpose of this 74-week RCT was to compare the long-term 
effect of diet on management of DM II by comparing individuals prescribed a vegan diet 
versus a diet based on 2003 American Diabetes Association (ADA) guidelines. 
Newspaper advertisements were used to recruit 99 participants in the Washington, DC 
area, a number decided upon from a statistical calculation indicating 49 participants per 
group were necessary in order to have an 80% chance of detecting a 0.8 difference of 
HbA1c between groups with a standard deviation (SD) of 1.3 and loss to follow-up of 
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33%. Inclusion criteria consisted of individuals who had been diagnosed with DM II and 
had used hypoglycemic medications for at least 6 months. Exclusion criteria included 
smoking, alcohol or drug abuse, pregnancy, medical instability, HbA1c <6.5 or >10.5%, 
use of insulin for >5 years, and current use of a low-fat vegetarian diet. Individuals were 
ranked in order of HbA1c concentrations and randomly assigned in sequential pairs, using 
a random-number table, to either a low-fat vegan diet (n=49) or a conventional diabetes 
diet following the 2003 guidelines of the ADA (n=50). The vegan diet consisted of whole 
grains, vegetables, legumes, and fruit and excluded animal products and fatty foods, such 
as added oils, fried foods, avocados, nuts and seeds. Subjects were asked to favor low-
glycemic index foods, and no restrictions were placed on carbohydrates, calories or 
portion size. Calories were divided among macronutrients in the following manner: 15% 
from protein, 10% from fat, and 75% from carbohydrates. The control diet was designed 
to derive 15-20% of calories from protein, <7% from saturated fat, and 60-70% from 
carbohydrates and monounsaturated fats. Cholesterol was limited to 200 mg per day. The 
control diet was individualized, based on body weight and plasma lipid concentrations, 
and energy intake deficits of 500-1 000 kcal were prescribed for those with a BMI >25. 
No meals were provided. All subjects met for 1 h with a registered dietitian to establish a 
dietary plan, followed by weekly cooking and nutrition classes for the first 22 weeks, and 
optional biweekly meetings thereafter. Adherence to the assigned diets was assessed with 
periodic submission of 3-day dietary records, in addition to unannounced telephone calls 
by dieticians to collect a 24-h diet recall. Participants were to continue their preexisting 
medications, but in the event of hypoglycemia, medications were reduced according to 
protocol by a study endocrinologist, who remained blind to group assignment. 
   12
Participants were asked not to alter their exercise habits for the first 22 weeks of the 
study, but were free to change habits for the following 52 weeks. Physical activity was 
assessed over 3-d periods by pedometry. The following were measured during the study 
by technicians who remained blind to group assignment: blood pressure, body weight, 
waist circumference, hip circumference, fasting plasma glucose, fasting plasma lipids, 
HbA1c, and urinary albumin.22 
 Results—Loss to follow-up was reported separately for laboratory assessments 
(n=7 vegan, n=5 conventional diet) and dietary records (n=9 vegan, n=7 conventional 
diet). Dietary adherence criteria were met by 67% of vegan participants at 22 weeks 
compared to 44% of control participants, and at 74 weeks, dietary adherence criteria were 
met by 51% and 48% respectively. Medication reductions and increases were noted in 
both groups, but the net 74-week dosages were reduced in 17 (35%) participants in the 
vegan group and 10 (20%) participants in the conventional diet group. The observed 
change in HbA1c from baseline to 74 weeks was -0.34 (+/- 0.19) and -0.14 (+/- 0.17) for 
vegan and conventional diets, respectively (P=0.43). In two additional analyses 
controlling for medication changes, significantly greater reductions were seen in HbA1c 
values in the vegan group. Changes from baseline to 74 weeks or to the last available 
value before any medication adjustment, were -0.40 (vegan) and 0.01 (control) (P=0.03). 
Among participants whose medications remained unchanged throughout (14 vegan, 21 
control), HbA1c changes for vegans were -0.82 and -0.21 for controls (P=0.14). Both 
groups sustained significant weight loss from baseline to 74 weeks, but there was no 
significant difference between diets (- 4.4 kg +/- 0.9 in vegan group, - 3.0 kg +/-0.8 in 
conventional diet group).22 
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Kahleova et al 
 The aim of this 24-week RCT was to compare the effects of vegetarian and 
conventional diabetes diets alone (0-12 weeks) and in combination with exercise (12-24 
weeks) on management of DM II as indicated by insulin resistance, visceral fat and 
oxidative stress markers. Individuals between the ages of 30 and 70 with DM II were pre-
chosen by their endocrinologists in Prague, Czech Republic. Inclusion criteria included 
HbA1c between 6 and 11%, BMI between 25 and 53 kg/m2, and a willingness to alter diet 
and exercise habits. Exclusion criteria included alcohol or drug abuse, pregnancy, 
lactation, HbA1c <6 or >11%, use of insulin, and current use of a vegetarian diet. 
Individuals were randomly assigned to either a vegetarian diet (n=37) or a conventional 
diabetes diet following the guidelines of the Diabetes and Nutrition Study Group of the 
European Association for the Study of Diabetes (n=37). Both diets were designed to be 
isocaloric and calorie-restricted. The vegetarian diet consisted of whole grains, 
vegetables, legumes, nuts and fruit. Animal products were limited to a portion of a low-
fat yogurt a day. Calories were divided among macronutrients in the following manner: 
15% from protein, 25% from fat, and 60% from carbohydrates. The control diet was 
designed to derive 20% of calories from protein, 30% from fat (<7% from saturated fat), 
and 50% from carbohydrates and monounsaturated fats. Cholesterol was limited to 200 
mg per day. All meals were provided during the study period, and participants met 
weekly for cooking and nutrition classes. Adherence to the assigned diets was assessed 
with periodic submission of 3-day dietary records, in addition to unannounced telephone 
calls by dieticians to collect a 24-h diet recall. Participants were to continue their 
preexisting medications, but in the event of hypoglycemia, a study physician reduced 
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medications according to protocol. During the first 12 weeks, subjects were asked to keep 
their exercise habits constant, and during weeks 13-24 they were to follow a prescribed 
exercise program. Physical activity was assessed over 3-d periods by pedometry and 
questionnaires. The following were measured during the study: blood pressure, body 
weight, waist circumference, fasting plasma glucose, fasting plasma lipids, HbA1c, insulin 
sensitivity as estimated by the metabolic clearance rate of glucose calculated during a 3-
hour hyperinsulinaemic isoglycaemic clamp, subcutaneous and visceral fat volume as 
measured by magnetic resonance imaging, oxidative stress markers and adipokines.23 
 Results—Loss to follow-up was reported as participant completion of the first 12 
weeks (95% vegetarian, 89% control) and again after 24 weeks (84% in each group). 
Adherence at 24 weeks was high among 55% of vegetarians and 32% of controls, 
medium among 22.5% of vegetarians and 39% of controls, and low among 22.5% of 
vegetarians and 29% of controls. Forty-three percent of participants in the vegetarian 
group reduced medications, compared to 5% in the control group. The difference between 
groups was 38% (95% CI 17-58%). HbA1c fell significantly in both groups in the first 12 
weeks prior to starting an exercise program [-0.68 (+/- 0.86) vegetarian, -0.59 (+/- 0.89) 
control, (P <0.001)], but the difference between groups was not significant (P=0.370). In 
sub-analysis including those whose medications remained constant, HbA1c fell 
significantly by 0.9% in the vegetarian group from baseline to 24 weeks vs. a non-
significant decrease of 0.2% in the control group. There was significant weight loss in 
both groups in response to the first 12 weeks of dietary interventions (P<0.001), but with 
greater weight loss in the vegetarian group than in the control group [- 6.2 kg (95% CI -
6.6 to -5.3) vs. - 3.2 kg (95% CI -3.7 to -2.5); P=0.001].23 
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I. DISCUSSION  
In this systematic review, a search of the current literature found studies 
comparing a vegan or vegetarian diet to a conventional diabetes diet with the outcome of 
improved management of diabetes type 2 as measured by reduction in medications, 
HbA1c and weight loss. Of the three studies reviewed, the vegan/vegetarian groups 
consistently indicated better outcomes over the conventional diets, with a significant 
reduction in medications, mild but not significant greater mean change of HbA1c, and a 
mixed report of significant and non-significant weight loss over that of the controls.21-23 
In analyses controlling for medications, the vegan diet appeared to be more effective for 
control of glycemia,22,23 suggesting that individuals with type 2 diabetes may be better 
managed on a plant-based diet. 
The greater weight loss observed in the vegan and vegetarian groups by the three 
studies in this review is consistent with large-scale population studies comparing weight 
differences among vegetarians and non-vegetarians3,5, and previous clinical trials directly 
comparing effects of a plant-based diet to a conventional low-fat diet7,10.  A systematic 
review by Berkow and Barnard (2006) examined the extent to which vegetarian diets are 
associated with reduced body weight, and identified 29 studies reporting that vegetarians 
weighed significantly less than non-vegetarians.9 Additionally, many studies have 
reported a consistent dose-dependent gradient that generally indicates BMI of vegans is 
lower than that of ovo-lacto-vegetarians, which is lower than that of individuals who eat 
moderate amounts of meat.3,5,24 Moreover, data suggest a greater ability to sustain weight 
reduction on a vegetarian diet. In a two-year randomized weight loss trial comparing a 
vegan diet to a National Cholesterol Education Program diet in overweight, 
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postmenopausal women, a vegan diet was associated with significant weight loss 
comparatively at 1 and 2 years.10  
The differences in weight loss between the two groups cannot fully be explained 
by differences in calorie consumption. Kahlova et al23 designed both groups to be 
isocaloric, and despite this, the vegetarian group lost more weight. Furthermore, 
regardless of the daily energy intake limits placed on the conventional diet groups, and 
lack thereof on the vegan groups, in the studies by Nicholson et al21 and Barnard et al,22 
significant weight loss was observed in the intervention groups, which is consistent with 
previous studies.7  
The observed weight loss of the intervention groups consistently correlates with 
reduction in medications and HbA1c among the 3 studies examined, and there is evidence 
from previous trials to suggest the glycemic effect of the vegan/vegetarian diet is at least 
partially mediated by weight loss.3,7,8,10 Kahleova et al23 reported a strong association 
among weight loss, reduction of visceral fat, and insulin sensitivity (two additional 
outcomes not evaluated in this review), suggesting a correlation of the three. As insulin 
sensitivity increases, blood glucose levels over time decrease, thus it would be reasonable 
to expect to observe a decrease in HbA1c to follow. In an analysis at 22 weeks by Barnard 
et al22, a regression model indicated a significant association with HbA1c and weight 
change, leading the authors to conclude the weight-reducing effect of the vegan diet was 
responsible for a substantial portion of its effect on HbA1c.6  
Several studies have sought to explain the observed difference between 
vegetarians and non-vegetarians in regards to weight loss and glycemic control. Much of 
the variance in body weight likely lies in the macronutrient differences of the diets, with a 
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lower proportion of fat and protein in a vegetarian diet and a greater amount of fiber.9,25 
Animal products are generally high in total and saturated fats, which, independent of 
body weight changes, have been associated with insulin resistance,8,14 a link that may be 
explained by lipid build-up in the cell membranes of skeletal muscle interfering with 
insulin receptor binding or affinity, and transport and cell signaling.26 Although a high-
protein, low-carbohydrate diet has generally been advocated for weight loss, many 
longer-term studies have indicated a positive correlation with BMI.5,9 In a recent 
prospective cohort study of 38 084 participants with a 10-yr follow-up suggests that 
consumption of 5% energy from both red meat or total protein at the expense of 
carbohydrates or fat increases diabetes risk as much as 30%.17 Likewise, Weickert et al 
concluded that a very high protein intake may have unfavorable effects on insulin 
sensitivity compared to a high cereal fiber diet.15 The connection between protein and 
insulin sensitivity may be related to the heme-iron content of meat, versus the non-heme 
iron of plant proteins. A number of studies have associated dietary heme-iron from meat 
with promoting oxidative stress and insulin resistance,18 and by reducing total body stores 
of heme-iron, insulin sensitivity increases.27 
Favorable patient-important outcomes of a plant-based diet include reducing 
medications, thereby reducing medical costs, in addition to lowering body weight and 
decreasing risk factors. Nonetheless, a vegan or vegetarian diet requires the patient to 
alter dietary habits, often in a radical way. Surprisingly, both Kahleova et al and Barnard 
et al demonstrated a higher adherence rate to the vegan/vegetarian diet over the 
conventional diabetes diet,22 particularly during exercise,23 and this has previously been 
documented.10 In a sub-analysis at the 22-week mark, Barnard et al concluded that the 
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vegan diet was as acceptable as the conventional diabetic diet, and although it requires 
greater effort initially, for some, it was simpler to follow without restrictions on calories, 
carbohydrates or portion size.28 
Limitations of the Studies 
It is important to note the limitations of the three studies analyzed in this review.  
 All studies had risk of recruitment bias. Nicholson et al21 and Barnard et al22 
screened applicants who responded to newspaper advertisements, limiting their 
population to those who read the newspaper and were motivated enough to respond to an 
advertisement. Kahleova et al23 screened individuals who were pre-chosen by their 
endocrinologists without mention of any randomized method, inviting the possibility of 
bias by hand-selecting certain patients. Additionally, by nature of design, all three trials 
excluded individuals who were not willing to change their diet, and in the case of 
Kahleova et al23, enter an exercise program after 12 weeks, which narrows participants to 
those who are motivated and may not represent the larger population of diabetics.  
 Although all studies were randomized, only Barnard et al22 described the 
randomization procedure, which excluded the need for allocation concealment since 
assignment to groups was done simultaneously. Blinding of participants and dieticians 
was not possible for either group across studies, due to the nature of diet as the testing 
modality. In cases where participants needed to have medications reduced due to 
hypoglycemic events, Barnard et al22 describes using a study endocrinologist that 
remained blinded to group assignment, but the other two authors make no mention of 
blinding physicians who decided whether medication changes were necessary.  
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 Two of the studies were limited by small sample size, thereby affecting precision. 
Nicholson et al21 recruited merely 13 patients, two of whom dropped out and were not 
included in final analyses. Kahleova et al23 included 37 participants in each group, which 
falls short of the calculation of by Barnard et al.22 
 There were several confounding factors that affected all three studies. Firstly, 
there is no foolproof way to monitor adherence to diet for people living independently, 
and the method utilized by all authors—3-day dietary records and unannounced phone 
calls to elicit recall of diet in the previous 24 hours—invokes the possibility of recall bias. 
Additionally, adherence to the assigned diet as reported by Barnard et al22 after 74 weeks 
was approximately 50% for both groups, with a relatively similar finding from Kahleova 
et al,23 which makes data interpretation difficult when only half the participants followed 
treatment guidelines. Secondly, exercise habits can have an affect on the outcomes of 
interest. Nicholson et al21 reported the participants of the vegan group exercised 
somewhat more at baseline than those in the control group, and this trend remained 
unchanged throughout the study. The other two studies found no significant difference 
between groups with regard to exercise, as monitored by pedometry readings and self-
reports. But again, self-reporting is not free from bias. Thirdly, the most profound 
confounder appears to be the medication changes required for patient safety, and the 
subsequent affect on HbA1c. In sub-group analyses, as demonstrated by Barnard et al22 
and Kahleova et al, 3 elimination of those participants whose medications were altered 
reduces the sample size and statistical power.  
 Finally, all studies reported averages for weight loss and HbA1c reductions 
without providing raw data. In this setting, if one participant makes a dramatic change the 
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entire mean score is influenced. It would have been more applicable for an endpoint if the 
studies had established a set value (pounds of weight lost or specific % drop in HbA1c) 
for participants to achieve, in order to calculate event rates.  
GRADE:  
The quality of evidence presented in each article was assessed using the GRADE 
criteria.29 In adults with Type 2 DM, a vegetarian or vegan diet was compared to a 
conventional diabetes diet by measuring three primary outcomes: medication reductions, 
HbA1c and weight loss (Table 2).   
Medication Reduction—All three studies reported medication reduction as an 
outcome, and all found a significant reduction in the experimental group compared to the 
control. Following the GRADE protocol, the studies began as high quality as indicated 
for RCT design. The outcome was downgraded two levels based on serious limitations 
identified in each trial, namely the inability to blind participants and dieticians to 
treatment groups. Additionally, Nicholson et al21 reported a large loss to follow up and 
did not abide by intention-to-treat analysis. It is worth mentioning that medication 
reduction was not stated as a primary outcome of any study, thus is classified as 
‘indirectness’ according to GRADE, however it is not considered a limitation because 
this is a patient-important outcome and confounds other primary outcomes. Imprecision, 
inconsistency and publication bias did not affect the quality assessment. The outcome 
was upgraded one level based on the large magnitude of effect as indicated in each study. 
Overall, the GRADE quality is moderate.  
HbA1c —Without accounting for medication changes, no study found a 
significant difference between the treatment groups in regards to reduction of HbA1c. 
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Following the same reasoning above, the HbA1c outcome was downgraded from high to 
low for lack of blinding across studies. Additionally, HbA1c was not a primary outcome 
of Kahleova et al23, and should be noted as an indirect measure, however it is not 
considered a factor that requires downgrading because it is universally utilized as an 
index of DM II management. Although the results from Barnard et al22 were precise, the 
other two studies were limited by imprecision, affecting the quality of the outcome by 
downgrading it one more level to very low. Further examination was not applicable, as a 
quality of ‘very low’ cannot be upgraded. However, it should be noted that confounding 
factors reduced the effect, as evidenced by sub-analyses performed by Barnard et al22 and 
Kahleova et al23 excluding those who had medication changes during the study period. 
Overall, the GRADE outcome is very low. 
Weight Loss—Two studies found significant decreases in weight loss among the 
vegetarian/vegan participants over those on the conventional diabetes diet, and Barnard et 
al22 reported similar results, but without statistical significance. Accordingly, weight loss 
was considered inconsistent among trials, and the quality was downgraded one level. As 
above, the outcome was downgraded two levels for serious limitations regarding 
blinding. Although no further downgrading could be applied, Barnard et al22 was the only 
study that demonstrated precision. No upgrades were applicable, as such the quality of 
weight loss as an outcome is very low. 
   
II. CONCLUSION  
 In conclusion, individuals with type 2 diabetes who participate in vegan and 
vegetarian diets effectively lose weight and have better glycemic control as measured by 
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medication reduction than those following a conventional diabetes diet. In analyses 
controlling for medication change, glycemic control is demonstrated further by reduction 
in HbA1c in the intervention group. Although motivating patients to change their dietary 
habits is certainly a challenge, a vegan or vegetarian diet without carbohydrate, caloric, or 
portion size restrictions may lend itself to patient-adherence and acceptability in the 
setting of long-term healthcare savings. Whether increased insulin sensitivity of the 
vegetarian group is strictly due to weight loss, or is a manifestation of specific properties 
of animal products has yet to be elucidated. 
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Table 1. Characteristics of Reviewed Studies 
 
 
 
Nicholson et al21 Barnard et al22 Kahleova et al23 
Study 
Design RCT RCT RCT 
Blinding None reported 
Endocrinologist who 
evaluated medications 
remained blind to group 
assignment 
Lab technicians remained 
blind 
None reported 
Number of 
Participant
s 
13, 11 included in analyses 99 74 
Age Range >25 27-82 30-70 
Study 
Duration 12 weeks 74 weeks 24 weeks 
Diet 
Classificati
on 
Vegan Vegan Vegetarian 
Diet 
Compositi
on 
Vegan 
Protein:       
10-15% 
Fat: <10% 
Carbohydrat
es: 75-80% 
Control 
Protein:       
10-15% 
Fat: <30% 
Carbohydrat
es: 55-60% 
Vegan 
Protein:     
15% 
Fat: 10% 
Carbohydrat
es: 75% 
Control 
Protein:       
15-20% 
Fat: 10-25% 
Carbohydrat
es: 60-70% 
Vegetarian 
Protein:         
15% 
Fat: 25% 
Carbohydrat
es: 60% 
Control 
Protein:     
20% 
Fat: <30% 
Carbohydrat
es: 50% 
 
Meals 
Provided Lunches, Dinners None Lunches, Dinners 
Adherence 
Assessmen
t 
3-day dietary records  
Weekly self-report 
questionnaires 
3-day dietary records 
Unannounced calls for 24-
hour diet recall 
3-day dietary records 
Unannounced calls for 24-
hour diet recall 
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Table 2. Summary of Findings, GRADE analyses    
 Quality Assessment Summary of Findings 
Importance  Downgrade Criteria Upgrade Criteria Study Number of Patients Effect 
Quality Number 
of 
studies 
Design  Limitations 
Indirect- 
ness Imprecision Inconsistency 
Publication 
bias  
Large 
magnitude 
of effect 
Confounding 
factors 
reducing 
effect 
Dose-
response 
gradient 
 
Vegan/ 
Vegetarian 
Diabetic 
Diet 
Vegan/ 
Vegetarian 
Diabetic 
Diet 
Medication Reduction 
 
  % of patients  
% of 
patients   
 
3 RCT Serious limitations* 
No 
indirectness** 
No 
imprecision+ 
No 
inconsistency None Large No None 
Nicholson 
et al21 7 4 
71 0 
Moderate Moderate 
RR = 71; NNT = 1 
Barnard 
et al22 49 50 
35 20 
RR = 1.8; NNT = 7 
Kahleova 
et al 23 37 37 
43 51 
RR = 8.6; NNT = 3 
HbA1c    Mean change  
Mean 
change    
3 RCT Serious limitations* 
No 
indirectness** 
 
Imprecision~ 
No 
inconsistency None N/A N/A*~ N/A 
Nicholson 
et al21 7 4 -1.4  -1.0 
Very Low Moderate 
Barnard 
et al22 49 50 
-0.34   
(SD: 0.19) 
-0.14    
(SD: 
0.17) 
Kahleova 
et al 23 37 37 
-0.68   
(SD: 0.86) 
-0.59 
(SD: 
0.89) 
Weight Loss    Mean loss  Mean loss    
3 RCT Serious limitations* 
No 
indirectness 
 
Imprecision~ 
 
Inconsistency
ⱡ
 
None  N/A N/A N/A 
Nicholson 
et al21 7 4 7.2 kg  3.8 kg  
Very Low Moderate 
Barnard 
et al22 49 50 
4.4 kg 
(SD: 0.9) 
3.0 kg 
(SD: 
0.8) 
Kahleova 
et al 23 37 37 
6.2 kg  
(CI: -6.6 to 
-5.3) 
3.2 kg 
(CI: -3.7 
to -2.5) 
* Participants were not blinded, and Nicholson et al21 had large loss to follow up and did not follow intention-to-treat analyses.  
** Outcome is not primary outcome of some studies, but is patient-important. 
+ Nicholson et al21 had a very small sample size, but this was incorporated into study limitations. 
~ Nicholson et al21 and Kahleova et al23 had wide CI, in part due to small sample size. 
ⱡ Barnard et al22 did not report a significant difference in weight loss between the two groups, unlike the other two studies. 
~* Medication reduction is a confounding factor for HbA1c values, but once a study has been downgraded to very low, there is no opportunity to upgrade.  
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